Literature DB >> 21958096

Using health technology assessment to support evidence-based decision-making in Canada: an academic perspective.

Feng Xie1, James M Bowen, Simone C Sutherland, Natasha Burke, Gord Blackhouse, Jean-Eric Tarride, Daria O'Reilly, Ron Goeree.   

Abstract

Health technology assessment (HTA) adopts a multidisciplinary approach to comprehensively assess safety, efficacy, effectiveness, economic and organizational impact, and any potential social and ethical implications associated with adoption and diffusion of a technology in a healthcare system. Canada was one of the first pioneers in using HTA as a research tool to support evidence-based decision-making. This article describes the current application of HTA in Canada, with a focus on some federal and Ontario initiatives in which the authors have extensive knowledge and experience to illustrate how academic researchers conduct HTA in collaboration with decision makers. Some issues and challenges are also highlighted that will hopefully stimulate a broader discussion among HTA stakeholders to move HTA forward.

Mesh:

Year:  2011        PMID: 21958096     DOI: 10.1586/erp.11.60

Source DB:  PubMed          Journal:  Expert Rev Pharmacoecon Outcomes Res        ISSN: 1473-7167            Impact factor:   2.217


  3 in total

1.  Management of Medical Technology under the New Medical Policy Background in China.

Authors:  Suo-Wei Wu; Tong Chen; Ming Wu; Qi Pan; Yong Xuan; Liang-Yu Wei; Qin Wang; Chao Li; Jing-Chen Song
Journal:  Chin Med J (Engl)       Date:  2016-11-20       Impact factor: 2.628

2.  Establishment of a Quantitative Medical Technology Evaluation System and Indicators within Medical Institutions.

Authors:  Suo-Wei Wu; Tong Chen; Qi Pan; Liang-Yu Wei; Qin Wang; Chao Li; Jing-Chen Song; Ji Luo
Journal:  Chin Med J (Engl)       Date:  2018-06-05       Impact factor: 2.628

3.  Emergency contraception subsidy in Canada: a comparative policy analysis.

Authors:  Sabrina C Lee; Wendy V Norman
Journal:  BMC Health Serv Res       Date:  2022-09-01       Impact factor: 2.908

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.